Clinical Trials
4 trialsNCT03737968 2023-03-21
Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients.
Yonsei University
Phase 2 Unknown
NCT05679856 2023-01-11
VC-Larynx
National Cancer Institute, Egypt
Phase NA Unknown
NCT04777474 2022-12-07
Benefit of Enhanced Contact Endoscopy in Pre-histological Diagnosis of Laryngeal and Hypopharyngeal Mucosal Lesions
University Hospital Ostrava
Phase NA Unknown
NCT00396617 2012-07-02
Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy
University Hospital, Strasbourg, France
Phase 1 Unknown